Ikena Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Ikena Oncology and buy or sell other stocks, ETFs, and their options commission-free!About IKNA
ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life.
CEOKristin Yarema, PhD
CEOKristin Yarema, PhD
Employees10
Employees10
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded
Founded
Employees10
Employees10
IKNA Key Statistics
Market cap5.75M
Market cap5.75M
Price-Earnings ratio-1.86
Price-Earnings ratio-1.86
Dividend yield—
Dividend yield—
Average volume6.24K
Average volume6.24K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$23.28
52 Week high$23.28
52 Week low$11.65
52 Week low$11.65
People also own
Based on the portfolios of people who own IKNA. This list is generated using Robinhood data, and it’s not a recommendation.